Skip to main content

Sex Differences in Risk Factors for Incident Sepsis Hospitalizations: A Prospective Cohort Study Using the UK Biobank.

The Journal of infectious diseases2025-03-06PubMed
Total: 74.0Innovation: 7Impact: 7Rigor: 8Citation: 7

Summary

In 490,783 UK Biobank participants, 21,468 had incident sepsis hospitalizations; men had higher age-standardized risk than women. COPD was the strongest risk factor with excess risk in women, and dyslipidemia, myocardial infarction, and smoking likewise conferred greater excess risk in women; dementia doubled risk among men.

Key Findings

  • Among 490,783 participants, 21,468 experienced incident sepsis hospitalization.
  • Men had higher age-standardized risk than women (40.2 vs 31.2 per 10,000 person-years; HR 1.26, 95% CI 1.23–1.29).
  • COPD was the strongest risk factor with excess risk in women (RHR 1.23, 95% CI 1.10–1.38).
  • Dyslipidemia (RHR 1.08, 95% CI 1.02–1.16), myocardial infarction (1.22, 1.05–1.41), and smoking (1.19, 1.09–1.29) conferred greater excess risk in women.
  • Dementia was associated with more than twice the risk of sepsis hospitalization in men (HR 2.21, 95% CI 1.37–3.55).

Clinical Implications

Clinicians should incorporate sex-stratified risk profiles into sepsis risk assessment: prioritize COPD, dyslipidemia, prior MI, and smoking in women, and recognize heightened risk with dementia in men to guide targeted prevention and vigilance.

Why It Matters

This large prospective analysis defines sex-specific risk gradients for sepsis, informing precision prevention and earlier recognition. It provides actionable evidence to tailor risk prediction and public health strategies.

Limitations

  • Observational design limits causal inference and may retain residual confounding.
  • Sepsis identified by hospitalization records may miss milder cases and be subject to misclassification.

Future Directions

External validation across diverse populations and age ranges; develop and test sex-specific sepsis risk scores; interventional studies targeting modifiable risks (e.g., smoking cessation, COPD optimization) with sepsis outcomes.

Study Information

Study Type
Cohort
Research Domain
Prevention
Evidence Level
II - Large prospective cohort study with multivariable modeling
Study Design
OTHER